Suppr超能文献

miR-520a-3p通过CCND1和CD44在乳腺癌中的抑制作用

Suppressing role of miR-520a-3p in breast cancer through CCND1 and CD44.

作者信息

Li Jun, Wei Juan, Mei Zhu, Yin Yongmei, Li Yongfei, Lu Mingjie, Jin Shidai

机构信息

Department of Medical Oncology, The First Affiliated Hospital with Nanjing Medical University Nanjing, P. R. China.

Department of Medical Oncology, The Second Affiliated Hospital with Southeast University Nanjing, P. R. China.

出版信息

Am J Transl Res. 2017 Jan 15;9(1):146-154. eCollection 2017.

Abstract

Recent studies show that many microRNAs (miRNAs) are found to play important roles in breast cancer, however, most of miRNAs are not investigated completely. In the present study, significant down-regulation of miR-520a-3p was found in the breast cancer tissues and cell lines. The restoration of miR-520a-3p expression in breast cancer cells could inhibit cell proliferation, migration and invasion. In addition, miR-520a-3p was able to induce breast cancer cell apoptosis. Luciferase assay was used to confirm that CCND1 and CD44 were the direct target genes of miR-520a-3p. The ectopic expression of miR-520a-3p repressed CCND1 and CD44 expression on post-transcriptional levels in breast cancer cells. This study suggests that miR-520a-3p may act as an optional method for breast cancer therapy.

摘要

最近的研究表明,许多微小RNA(miRNA)在乳腺癌中发挥重要作用,然而,大多数miRNA尚未得到充分研究。在本研究中,发现乳腺癌组织和细胞系中miR-520a-3p显著下调。恢复乳腺癌细胞中miR-520a-3p的表达可抑制细胞增殖、迁移和侵袭。此外,miR-520a-3p能够诱导乳腺癌细胞凋亡。荧光素酶报告基因实验用于证实CCND1和CD44是miR-520a-3p的直接靶基因。miR-520a-3p的异位表达在转录后水平抑制乳腺癌细胞中CCND1和CD44的表达。本研究表明,miR-520a-3p可能成为乳腺癌治疗的一种选择方法。

相似文献

1
Suppressing role of miR-520a-3p in breast cancer through CCND1 and CD44.
Am J Transl Res. 2017 Jan 15;9(1):146-154. eCollection 2017.
3
Lidocaine inhibits proliferation and induces apoptosis in colorectal cancer cells by upregulating mir-520a-3p and targeting EGFR.
Pathol Res Pract. 2018 Dec;214(12):1974-1979. doi: 10.1016/j.prp.2018.09.012. Epub 2018 Sep 13.
5
MicroRNA-520a-3p inhibits cell growth and metastasis of non-small cell lung cancer through PI3K/AKT/mTOR signaling pathway.
Eur Rev Med Pharmacol Sci. 2018 Apr;22(8):2321-2327. doi: 10.26355/eurrev_201804_14822.
6
A Novel Role for MiR-520a-3p in Regulating EGFR Expression in Colorectal Cancer.
Cell Physiol Biochem. 2017;42(4):1559-1574. doi: 10.1159/000479397. Epub 2017 Jul 24.
9
HIF1α/miR-520a-3p/AKT1/mTOR Feedback Promotes The Proliferation And Glycolysis Of Gastric Cancer Cells.
Cancer Manag Res. 2019 Dec 2;11:10145-10156. doi: 10.2147/CMAR.S223473. eCollection 2019.
10
Dexmedetomidine inhibits cell malignancy in osteosarcoma cells via miR-520a-3p-YOD1 interactome.
Biochem Biophys Res Commun. 2021 Mar 5;543:56-64. doi: 10.1016/j.bbrc.2021.01.045. Epub 2021 Jan 27.

引用本文的文献

1
Non-Coding RNAs Modulating Estrogen Signaling and Response to Endocrine Therapy in Breast Cancer.
Cancers (Basel). 2023 Mar 7;15(6):1632. doi: 10.3390/cancers15061632.
2
LncRNA SBF2-AS1 Facilitates Nonsmall Cell Lung Cancer Progression by Targeting miR-520a-3p.
J Healthc Eng. 2022 Apr 11;2022:2223149. doi: 10.1155/2022/2223149. eCollection 2022.
4
Lidocaine has antitumor effect on hepatocellular carcinoma via the circ_DYNC1H1/miR-520a-3p/USP14 axis.
Open Life Sci. 2021 Aug 9;16(1):766-780. doi: 10.1515/biol-2021-0072. eCollection 2021.
5
7
MicroRNA-520a Suppresses Pathogenesis and Progression of Non-Small-Cell Lung Cancer through Targeting the RRM2/Wnt Axis.
Anal Cell Pathol (Amst). 2021 Mar 30;2021:9652420. doi: 10.1155/2021/9652420. eCollection 2021.
8
LncRNA FGD5-AS1 accelerates cell proliferation in pancreatic cancer by regulating miR-520a-3p/KIAA1522 axis.
Cancer Biol Ther. 2021 Mar 4;22(3):257-266. doi: 10.1080/15384047.2021.1883184. Epub 2021 Apr 2.
10
miR‑302c‑3p and miR‑520a‑3p suppress the proliferation of cervical carcinoma cells by targeting CXCL8.
Mol Med Rep. 2021 May;23(5). doi: 10.3892/mmr.2021.11961. Epub 2021 Mar 24.

本文引用的文献

1
Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development.
Oncotarget. 2016 Feb 16;7(7):8341-59. doi: 10.18632/oncotarget.7071.
2
Revealing the Complexity of Breast Cancer by Next Generation Sequencing.
Cancers (Basel). 2015 Nov 6;7(4):2183-200. doi: 10.3390/cancers7040885.
3
MicroRNA Processing and Human Cancer.
J Clin Med. 2015 Aug 21;4(8):1651-67. doi: 10.3390/jcm4081651.
4
MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer.
Theranostics. 2015 Jul 13;5(10):1122-43. doi: 10.7150/thno.11543. eCollection 2015.
5
MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients.
Br J Cancer. 2015 Aug 11;113(4):569-73. doi: 10.1038/bjc.2015.253. Epub 2015 Jul 9.
8
MicroRNAs as potential biomarkers in cancer: opportunities and challenges.
Biomed Res Int. 2015;2015:125094. doi: 10.1155/2015/125094. Epub 2015 Mar 22.
9
The Roles of MicroRNAs in Breast Cancer.
Cancers (Basel). 2015 Apr 9;7(2):598-616. doi: 10.3390/cancers7020598.
10
MicroRNA profiling identifies MiR-195 suppresses osteosarcoma cell metastasis by targeting CCND1.
Oncotarget. 2015 Apr 20;6(11):8875-89. doi: 10.18632/oncotarget.3560.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验